Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

Paul Emery,Patrick Durez,Maxime Dougados,Clarence W. Legerton,Jean-Claude Becker,George Vratsanos,Harry K. Genant,Charles Peterfy,Pranab Mitra,Sandra Overfield,Keqin Qi,Rene Westhovens

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

2010

Paul Emery
Patrick Durez
Maxime Dougados
Clarence W. Legerton
Jean-Claude Becker
George Vratsanos
Harry K. Genant
Charles Peterfy
Pranab Mitra
Sandra Overfield
Keqin Qi
Rene Westhovens

Several agents provide treatment for established rheumatoid arthritis (RA), but a crucial therapeutic goal is to delay/prevent progression of undifferentiated arthritis (UA) or very early RA.

Keywords:

Inflammatory arthritis
Abatacept
Arthritis
Rheumatology
Rheumatoid arthritis
Rheumatoid factor
Antirheumatic Agents
Immunology
Medicine
Internal medicine
Synovitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

192

Citations